liveBook · Manning

Drug-like molecule

As explained in Build AI Drug Discovery Pipelines

A drug-like molecule is a chemical compound with properties broadly compatible with functioning as a medicinal drug.

A drug-like molecule is a chemical compound with properties broadly compatible with functioning as a medicinal drug. Drug discovery searches for such compounds because the space of possible molecules is vast, biological systems are complex, and safety standards are rigorous. section 1.0

The molecule is considered alongside a biological target: a protein, nucleic acid, lipid, or carbohydrate whose activity may be modulated to produce a medicinal effect. Binding depends on physical interactions between flexible molecular and target conformations; their association strength is called binding affinity. section 1.1.1

Drug-like molecules matter in discovery because they:

  • Occupy an enormous chemical search space, estimated at 10^63 molecules. section 1.1.1
  • Must be found in relation to a chosen biological target rather than evaluated uniformly against every possible protein. section 1.1.1
  • Can be prioritized through computational screening and machine-learning methods before extensive experimental work. section 1.0
Figure 1.1 Drug discovery can be thought of as a difficult search problem that exists at the intersection of the chemical search space of 1063 drug-like compounds and the biological search space of 105 targets.

Maps drug discovery to the intersection of the chemical search space of drug-like compounds and the biological search space of targets. section 1.1.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Defines the term and relates it to targets, binding affinity, molecular flexibility, and the scale of chemical search.
Examples
Uses the 10^63-molecule estimate, a grains-of-sand analogy, and flexible target-protein binding as concrete illustrations.
What it assumes
Builds target, binding, and affinity vocabulary while assuming no specific chemistry or machine-learning background.
What you can do after
Evaluate drug-like molecules as computationally screenable candidates for activity against selected biological targets.
How it connects
Connects drug-like molecules to drug discovery, biological targets, binding affinity, chemical search spaces, and machine learning.

Related concepts

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.